PULMATRIX, INC. Class of Warrant or Right, Outstanding
PULMATRIX, INC. (PULM) had Class of Warrant or Right, Outstanding of 65.00 thousand shares as of 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-09-17
- 2026-06-30: Class of Warrant or Right, Outstanding 65.00K shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 65.00K shares.
- 2024-12-31: Class of Warrant or Right, Outstanding 535.83K shares.
- 2024-06-30: Class of Warrant or Right, Outstanding 160.44K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 65.00K shares S-4/A · filed 2026-09-17 |
| 2026-03-31 | 65.00K shares S-4/A · filed 2026-08-03 |
| 2024-12-31 | 535.83K shares 10-Q · filed 2025-08-06 |
| 2024-06-30 | 160.44K shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 7.79K shares 10-Q · filed 2024-05-10 |
| 2019-12-31 | 18.95M shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 18.95M shares 10-Q · filed 2019-11-01 |
| 2019-06-30 | 19.32M shares 10-Q · filed 2019-08-05 |
| 2019-03-31 | 5.59M shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 4.43M shares 10-K · filed 2020-03-26 |
| 2018-09-30 | 5.26M shares 10-Q · filed 2019-11-01 |
| 2018-06-30 | 5.26M shares 10-Q · filed 2019-08-05 |
| 2018-03-31 | 324.52K shares 10-Q · filed 2019-05-15 |
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-13 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |